Literature DB >> 29380182

Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas.

Jason Yongsheng Chan1,2,3, Soon Thye Lim4,5,6.   

Abstract

T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research.

Entities:  

Keywords:  Enteropathy-associated T-cell lymphoma; Epstein–Barr virus; JAK-STAT pathway; NK/T-cell lymphoma

Mesh:

Year:  2018        PMID: 29380182     DOI: 10.1007/s12185-018-2406-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  41 in total

Review 1.  Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines.

Authors:  Daryl Tan; Soo Yong Tan; Soon Thye Lim; Seok Jin Kim; Won-Seog Kim; Ranjana Advani; Yok-Lam Kwong
Journal:  Lancet Oncol       Date:  2013-11       Impact factor: 41.316

2.  A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.

Authors:  Mohamad Farid; Ying Wei Yau; Kevin Tay; Richard Quek; Miriam Tao; Ghee Chong Koo; Susan Loong; Soon Thye Lim
Journal:  Acta Oncol       Date:  2011-01-12       Impact factor: 4.089

3.  Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.

Authors:  Y Yang; Y-J Zhang; Y Zhu; J-Z Cao; Z-Y Yuan; L-M Xu; J-X Wu; W Wang; T Wu; B Lu; S-Y Zhu; L-T Qian; F-Q Zhang; X-R Hou; Q-F Liu; Y-X Li
Journal:  Leukemia       Date:  2015-02-20       Impact factor: 11.528

4.  Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Authors:  Seok Jin Kim; Kihyun Kim; Byung Soo Kim; Chul Yong Kim; Cheolwon Suh; Jooryung Huh; Sang-Wook Lee; Jin Seok Kim; Jaeho Cho; Gyeong-Won Lee; Ki Mun Kang; Hyeon Seok Eom; Hong Ryull Pyo; Yong Chan Ahn; Young Hyeh Ko; Won Seog Kim
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

5.  SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.

Authors:  Yok-Lam Kwong; Won Seog Kim; Soon Thye Lim; Seok Jin Kim; Tiffany Tang; Eric Tse; Anskar Y H Leung; Chor-Sang Chim
Journal:  Blood       Date:  2012-08-23       Impact factor: 22.113

6.  Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose.

Authors:  Karthik Venkatakrishnan; Tae Min Kim; Chia-Chi Lin; Lim Soon Thye; Wee Joo Chng; Brigette Ma; Ming Huang Chen; Xiaofei Zhou; Hua Liu; Virginia Kelly; Won Seog Kim
Journal:  Invest New Drugs       Date:  2015-06-19       Impact factor: 3.850

7.  Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.

Authors:  Lu Jiang; Zhao-Hui Gu; Zi-Xun Yan; Xia Zhao; Yin-Yin Xie; Zi-Guan Zhang; Chun-Ming Pan; Yuan Hu; Chang-Ping Cai; Ying Dong; Jin-Yan Huang; Li Wang; Yang Shen; Guoyu Meng; Jian-Feng Zhou; Jian-Da Hu; Jin-Fen Wang; Yuan-Hua Liu; Lin-Hua Yang; Feng Zhang; Jian-Min Wang; Zhao Wang; Zhi-Gang Peng; Fang-Yuan Chen; Zi-Min Sun; Hao Ding; Ju-Mei Shi; Jian Hou; Jin-Song Yan; Jing-Yi Shi; Lan Xu; Yang Li; Jing Lu; Zhong Zheng; Wen Xue; Wei-Li Zhao; Zhu Chen; Sai-Juan Chen
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 38.330

8.  Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.

Authors:  Yoshinori Ito; Hiroshi Kimura; Yoshinobu Maeda; Chizuko Hashimoto; Fumihiro Ishida; Koji Izutsu; Noriyasu Fukushima; Yasushi Isobe; Jun Takizawa; Yuichi Hasegawa; Hajime Kobayashi; Seiichi Okamura; Hikaru Kobayashi; Motoko Yamaguchi; Junji Suzumiya; Rie Hyo; Shigeo Nakamura; Keisei Kawa; Kazuo Oshimi; Ritsuro Suzuki
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

9.  JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.

Authors:  M-L Nairismägi; J Tan; J Q Lim; S Nagarajan; C C Y Ng; V Rajasegaran; D Huang; W K Lim; Y Laurensia; G C Wijaya; Z M Li; I Cutcutache; W L Pang; S Thangaraju; J Ha; L P Khoo; S T Chin; S Dey; G Poore; L H C Tan; H K M Koh; K Sabai; H-L Rao; K L Chuah; Y-H Ho; S-B Ng; S-S Chuang; F Zhang; Y-H Liu; T Pongpruttipan; Y H Ko; P-L Cheah; N Karim; W-J Chng; T Tang; M Tao; K Tay; M Farid; R Quek; S G Rozen; P Tan; B T Teh; S T Lim; S-Y Tan; C K Ong
Journal:  Leukemia       Date:  2016-02-08       Impact factor: 11.528

10.  Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.

Authors:  Seungbok Lee; Ha Young Park; So Young Kang; Seok Jin Kim; Jinha Hwang; Seungho Lee; Soo Heon Kwak; Kyong Soo Park; Hae Yong Yoo; Won Seog Kim; Jong-Il Kim; Young Hyeh Ko
Journal:  Oncotarget       Date:  2015-07-10
View more
  3 in total

1.  Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma.

Authors:  Dachuan Huang; Jing Quan Lim; Daryl Ming Zhe Cheah; Khalilatul Hanisah Binte Mohd Kahliab; Yurike Laurensia; Jane Wan Lu Pang; Esther Kam Yin Wong; Burton Kuan Hui Chia; Jasmine Goh; Xiyun Zhang; Jason Yongsheng Chan; Edward Kai-Hua Chow; Soo Yong Tan; Soon Thye Lim; Choon Kiat Ong
Journal:  Blood Adv       Date:  2020-10-13

2.  Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination.

Authors:  Yu Wang; Cai-Qin Wang; Peng Sun; Pan-Pan Liu; Hang Yang; Han-Yu Wang; Hui-Lan Rao; Su Li; Wen-Qi Jiang; Jia-Jia Huang; Zhi-Ming Li
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

3.  Clinical impact of lymphatic spread in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma.

Authors:  Moo-Kon Song; Joo-Seop Chung; Sung-Yong Oh; Sung-Nam Lim; Won-Sik Lee; Sang-Min Lee; Do-Young Kim
Journal:  Blood Res       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.